2022
DOI: 10.1016/j.lanwpc.2022.100487
|View full text |Cite
|
Sign up to set email alerts
|

State-wide genomic epidemiology investigations of COVID-19 in healthcare workers in 2020 Victoria, Australia: Qualitative thematic analysis to provide insights for future pandemic preparedness

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3
1

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 32 publications
0
2
0
Order By: Relevance
“…They also found that booster protection remained largely stable for at least 16 weeks after vaccination [32] . Moreover, staff-to-staff and staff-to-patient transmission is a major driver of SARS-CoV-2 dissemination in healthcare facilities [33] , [34] , [35] . Real-life data found significantly lower SARS-CoV-2 viral loads in upper respiratory tract during the first five symptomatic days in boosted patients with Omicron breakthrough infections compared to unvaccinated infected patients [36] .…”
Section: Discussionmentioning
confidence: 99%
“…They also found that booster protection remained largely stable for at least 16 weeks after vaccination [32] . Moreover, staff-to-staff and staff-to-patient transmission is a major driver of SARS-CoV-2 dissemination in healthcare facilities [33] , [34] , [35] . Real-life data found significantly lower SARS-CoV-2 viral loads in upper respiratory tract during the first five symptomatic days in boosted patients with Omicron breakthrough infections compared to unvaccinated infected patients [36] .…”
Section: Discussionmentioning
confidence: 99%
“…Genomic epidemiology draws together bioinformatic analysis from pathogen genomic sequences and epidemiological data to provide context and support to inferences of transmission. Synthesis of genomic and epidemiological data is required to perform these inferences, however this can be challenging given the complexity of the underlying data [4]. These challenges can be compounded when genomic and epidemiological investigations are conducted by discrete organisations (for example public health laboratories and local public health services respectively) with different information contexts and objectives.…”
mentioning
confidence: 99%